Obese and type 2 diabetic (T2DM) adolescents present with reduced insulin-stimulated glucose disposal and elevated intramyocellular lipids (IMCL) indicating comparable muscular insulin resistance and increased flux of free fatty acids (FFA) as in adult patients. In humans, the causal relationships between obesity and insulin resistance were examined in detail over the last years. METHODS: The impact of genetic factors was analyzed in young nonobese nondiabetic first-degree relatives of T2DM (REL-DM), whereas environmental factors were tested by challenging humans without genetic T2DM risk with lipid infusions or high-fat diets. RESULTS: REL-DM exhibit defects in mitochondrial oxidation and phosphorylation. Increased FFA availability results in accumulation of intramyocellular fatty acyl-CoA (FA-CoA) inducing a series of alterations: (i) inhibition of insulin signaling, (ii) reduction of insulin-(in)dependent glucose transport/phosphorylation, (iii) decreased insulin-stimulated glycogen synthesis, (iv) impaired insulin-stimulated oxidative phosphorylation (ATP synthesis), (v) accumulation of ectopic triglycerides (IMCL), (vi) reduced expression of peroxisome proliferator activated receptor g (PPARg) coactivator-1 (PGC-1) and PGC-1-controlled genes involved in mitochondrial biogenesis and oxidative phosphorylation and possibly also (vii) initiation of inflammatory processes by activation of PKC and nuclear factor-kB and decreased expression of matrix metalloproteinases (MMPs). CONCLUSIONS: The abnormalities could lead to a vicious cycle in which mitochondrial dysfunction, elevation of intramycellular lipids, impaired lipid oxidation and insulin resistance amplify each other. This is similar to the adaptive changes to fasting, which prevent energy loss during excessive FFA availability. The sequence of events may start with mitochondrial dysfunction in genetic insulin resistance and with increased intramyocellular lipids in environmental insulin resistance.
Background
The worldwide rise in the prevalence of type 2 diabetes mellitus (T2DM) is generally explained by an increase of the elderly population particularly in industrialized nations and of overweight and obesity also in less industrialized regions. The rise in obesity is related to overnutrition with fat-containing and high-caloric foods and lack of appropriate exercise. As this behavior becomes more and more common in adolescents and even children, obesity and related diseases now appear at a younger age.
Obesity, T2DM and insulin resistance in adolescents
Obesity primarily determines the risk of the metabolic syndrome, which can be defined in analogy to adults by occurrence of three out of the five criteria, abdominal (visceral obesity), increased plasma triglycerides, decreased HDL cholesterol, elevated blood pressure and plasma glucose. Applying these criteria, the prevalence of the metabolic syndrome rose by 50% from 4.2 to 6.4% between 1988 and 2000 in the National Health and Nutrition Surveys (NHANES) and is now present in B32% of overweight adolescents 1 and in B50% of severely obese youngsters. 2 Of note, the metabolic syndrome is tightly associated with impaired sensitivity of peripheral tissues to insulin, that is, insulin resistance, independently of the degree of obesity. Although this suggests that fat mass is of major importance, it is still unclear which components of the metabolic syndrome, are directly responsible for the development of overt diabetes.
Typically, adolescents with overt T2DM are markedly obese, have reached puberty and have a positive family history of T2DM (first degree relatives of T2DM, REL-DM) and/or belong to ethnic minority groups. Impaired glucose tolerance (IGT) upon oral glucose challenge is present in 20-25% of obese youngsters and defines the prediabetic state preceding overt diabetes, which occurs in B4% of obese adolescents. 3 Prediabetes in youngsters, that is, combined IGT and obesity, is associated with insulin resistance, while insulin secretion by pancreatic b-cell seems to be preserved until overt diabetes develops. This prediabetic state is further characterized by slightly higher visceral fat mass, accumulation of fat within skeletal muscle cells (intramyocellular lipids, IMCL) both of which negatively correlate with insulin sensitivity and glucose tolerance status. 4 Such positive relationship between insulin resistance and IMCL has been demonstrated in healthy nondiabetic, 5 REL-DM 6 and women with previous gestational diabetes. 7 These findings suggest that the metabolic syndrome and IGT are characterized by excessive lipid availability and define the abnormalities of insulin-sensitive cells such as myocytes, hepatocytes and possibly endothelial cells, whereas abnormalities of insulin secretion by pancreatic b cell are responsible for the transition from IGT to overt T2DM.
Muscular insulin resistance
Insulin resistance is defined as impaired whole body glucose disposal during insulin-stimulation when the majority of glucose is disposed to skeletal muscle and almost exclusively metabolized nonoxidatively to glycogen. Continuous measurement of intramyocellular concentrations of glucose-6-phosphate and glycogen with noninvasive 31 P and 13 C magnetic resonance spectroscopy (MRS) revealed that insulin resistance is associated with reduction in insulinstimulated glucose transport/phosphorylation followed by decreased glycogen synthesis in obese and overt T2DM. 8 These defects are already present in young nonobese nondiabetic REL-DM and can be only partly normalized by exercise training. 9 Thus, both environmental and genetic factors contribute to abnormalities of skeletal muscle metabolism. Since skeletal muscle is responsible for most of the impairment of glucose metabolism in insulin-resistant states, this review focuses on the role of skeletal muscle, although other tissues particularly liver and endocrine pancreas and vasculature are also important for the understanding of insulin resistance and T2DM.
Genetic insulin resistance
In an attempt to eliminate acquired and environmental factors, recent studies selected first REL-DM with mean age of less than 32 y, mean BMI less than 25 kg/m 2 and without evidence for visceral obesity and matched these groups carefully for all relevant anthropometric and metabolic variables to individuals without any family history of diabetes mellitus. The REL-DM presented with 20-50% lower insulin sensitivity, but 20% higher plasma free fatty acids (FFA) concentrations and 65% higher IMCL in soleus muscle. 6 Plasma FFA and IMCL in soleus, but not in tibialis anterior muscle, were the primary determinants of the degree of insulin resistance. Soleus muscle is prevalently composed of the insulin-sensitive slow-twitch oxidative type I fibers suggesting that defects in oxidative pathways in addition to increased lipid delivery to muscle could explain the increase of IMCL. The relative roles of lipid delivery and intramyocellular metabolism were studied in a similarly selected group of lean REL-DM featuring 60% lower insulin sensitivity and 80% higher IMCL in soleus muscle compared with their age-and body fat mass-matched control group. 10 Comparable fasting and insulin-mediated suppression of glycerol turnover and interstitial glycerol levels indicate that differences in FFA delivery cannot explain the insulin resistance in this population. On the other hand, the mean rate of unidirectional ATP synthesis as measured from magnetization saturation transfer between intramyocellular ATP and inorganic phosphate (Pi) using noninvasive 31 P MRS was 30% lower in the REL-DM. The ratio between Pi and phosphocreatine (PCr) was 20% lower, suggesting a lower proportion of the mitochondria-rich type I fibers in soleus muscle of the insulin-resistant group. Of note, plasma concentrations of adipocyte-derived cytokines such as interleukin-6, tumor necrosis factor-a, resistin and adiponectin, which have been implicated in the pathogenesis of insulin resistance, 11 were not different between these lean insulinresistant and insulin-sensitive individuals. Taken together, these studies allow the hypothesis that genetic defects of muscle fiber composition, mitochondrial function or biogenesis can lead to inefficient lipid oxidation, accumulation of intracellular lipids and insulin resistance. In line with this contention, the Gly486Ser polymorphism of the PGC-1 gene has been linked to the risk of T2DM in a Caucasian population. 12 PGC-1 is a central transcriptional regulator of mitochondrial biogenesis and function by controlling expression of genes responsible for oxidative phosphorylation (OXPHOS genes). Nevertheless, a direct causal relationship between genes controlling mitochondrial function and insulin resistance or T2DM remained to be proven.
Environmental insulin resistance
Despite the potential role of genetic factors, in adolescents it is the degree of obesity which primarily determines the rise in insulin resistance, visceral and intramyocellular lipid contents. 4 In parallel, plasma triglycerides markedly increase by 70% and by 115% from normal weight to overweight and slightly obese adolescents. 2 These findings corroborate the hypothesis that augmented lipid availability is critical for the development of environmentally induced insulin resistance in obesity. The lack of detectable alterations in fasting plasma FFA despite increased body fat mass in these young obese IGT 4 does not contradict this hypothesis. The prevailing hyperinsulinemia could be sufficient to suppress lipolysis under these conditions. Indeed, insulin suppression of plasma FFA and glycerol turnover were not impaired in these obese IGT individuals. Nevertheless, plasma FFA concentrations are generally increased in insulin-resistant humans such as obese, REL-T2DM and T2DM and correlate with the degree of hyperglycemia, skeletal muscle insulin resistance and the risk of developing T2DM. 13 In order to examine the early effects of augmented lipid availability in the development of insulin resistance, infusion of lipid emulsions can be employed combined with or without heparin to increase plasma FFA from triglyceride breakdown by stimulating lipoprotein lipase and to achieve plasma FFA concentrations ranging from 0.5 to 2.5 mM in young healthy nonobese humans. 13, 14 Using this approach,
we found that a 10-fold elevation of plasma FFA inhibits insulin-stimulated glucose transport/phosphorylation as assessed from the 60% lower rise in intramyocellular glucose-6-phosphate measured with noninvasive 31 P MRS. This was followed by reductions in glucose oxidation by 40% after 2 h, insulin-stimulated glucose disposal by 46% and muscular glycogen synthesis by 50% starting at 3 h of lipid/heparin infusion. 15 Further, plasma FFA concentrationdependently inhibit insulin-stimulated glucose disposal and the increase in glucose-6-phosphate, which is blunted by B25% already at 45 min, 16, 17 and reduce the intramyocellular free glucose concentration suggesting that FFA primarily inhibit glucose transport. 18 Under these conditions, IMCL increase after 4 h of plasma FFA elevation. 19 Recently, we demonstrated that the FFA-induced 46% decrease in whole body glucose metabolism and 70% lower rise of intramyocellular glucose-6-phosphate occurs without significant changes in IMCL, but is associated with 24% lower mitochondrial phosphorylation assessed with noninvasive saturation transfer 31 P MRS in soleus muscle. 20 Impairment of insulin-stimulated ATP production was also demonstrated in vastus lateralis muscle from overt T2DM. 21 Taken together, augmented lipid availability as induced by raising plasma FFA causes insulin resistance in nonobese insulinsensitive humans, which can be explained by reduction of glucose transport and is paralleled by impaired ATP synthase flux before any changes in IMCL. In order to examine the cellular mechanisms by which augmented lipid availability interferes with insulin action and glucose metabolism, lipid infusion protocols were combined with repetitive biopsies of vastus lateralis muscle (Figure 1 ). Plasma FFA elevation almost completely abolished the increase in insulin receptor substrate (IRS)-1-associated phosphoinositide-3 kinase (PI3K). 18 When insulin-stimulated glucose disposal was reduced by 34% after 4 h of lipid infusion, FFA elevation concentration-dependently inhibited by 53-55% not only tyrosine phosphorylation of the insulin receptor and IRS-1, IRS1-PI3 K activity but also serine phosphorylation of Akt, which is controlled by ceramide and activates GLUT-4 and glycogen synthase. 22 After 6 h of lipid infusion, the 43% reduction in whole body glucose disposal was accompanied by a three-fold increase in diacylglycerol (DAG), four-fold increase in protein kinase C (PKC) activity with recruitment of the b and d isoforms of PKC to the cell membrane as well as a 70% decrease of IkB-a, an inhibitor of nuclear factor-kB (NFkB), which comprises dimeric transcription factors. 23 Both PKC isoforms and NFkB could contribute to insulin resistance by regulating phosphorylation of serine and threonine residues of IRS proteins. Taken together, increased lipid availability due to either circulating plasma FFA or triglycerides or from IMCL could lead to elevated FA-CoA and translocation of PKC isoforms to the muscle cell membrane. This activation of PKC may stimulate the IkB-a/NFkB system or directly phosphorylate serine residues of the insulin receptor and its substrates. This will in turn inhibit the activity of IRS-associated PI3K, which is mainly responsible for the insulin-induced recruitment of GLUT-4 to the cell membrane, and ultimately inhibit glucose transport. 13 While these mechanisms describe the short-term effects of plasma FFA concentrations, long-term effects were studied by using prolonged lipid infusion or high-fat dietary regimen. A rise of plasma FFA for 48 h decreased the expression PGC-1 and a series of nuclear encoded mitochondrial genes. 24 Likewise a high-fat isocaloric diet for 3 days resulted in reduction of the expression of OXPHOS genes belonging to mitochondrial complex I, II and one mitochondrial carrier protein as well as reduction by 20 and 25% of PGC-1a and PGC-1b. 25 Of note, dietary-induced increases in circulating and sarcolemmal fatty acids depend on the amount and quality of the ingested fat in that insulin resistance seems to relate to elongation and desaturation of fatty acids in the outer layers of the sarcolemma in human skeletal muscle.
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T2DM, but also nondiabetic obese humans feature marked abnormalities in mitochondrial form, distribution and Muscle triglycerides and mitochondrial function M Roden function. 27 In skeletal muscle, mitochondria are located either between myofibrillar structures or beneath the cell membrane. Intrafibrillar mitochondria are head responsible for energy support for muscle contraction, whereas the subsarcolemmal mitochondria provide energy for energy consuming processes such as transport of ions and metabolites. Overall electron transport chain activity is reduced by more than 50% in obese and T2DM. In particular, subsarcolemmal electron transport is four-fold lower in obese and seven-fold lower in T2DM compared with matched lean humans. Thickness of the subsarcolemmal layer and mitochondrial DNA content were also lower in obese and T2DM, but the decrement in the amount of subsarcolemmal mitochondria was smaller than the decrement in electron chain activity. This suggests that in addition to reduced mitochondrial amount another defect in mitochondrial function is present not only in overt T2DM but even in obese nondiabetic humans. As a result of the postulated role of subsarcolemmal mitochondria for glucose transport and lipid oxidation, this observation might be of relevance for the link between mitochondrial dysfunction and insulin resistance. The findings that lipid oxidation and FFA utilization are decreased in insulin-resistant states 28 and that expression of PGC-1 and PGC-1 controlled mitochondrial genes involved in electron transport, oxidative phosphorylation including ATP synthase is impaired in overt T2DM strengthens this hypothesis. 29, 30 Although not yet proven in humans, nutrient oversupply with lipids could decrease PGC-1 by activation of the mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway, 30 which upon activation by amino acids can also directly induce insulin resistance by serine phosphorylation of IRS-1 in human skeletal muscle. 31, 32 Another exogenous factor contributing to mitochondrial dysfunction and insulin resistance could reside in the chances occurring during aging. Aging is associated with a fall in insulin sensitivity and an increasing prevalence of manifestation of T2DM. The relationship between insulin resistance, intracellular lipids and mitochondrial metabolism was recently studied by combining 1 33 Impairment by 35% of insulin-stimulated glucose disposal was associated with a 45% increase in IMCL in soleus muscle. The elderly had 35 and 46% lower mitochondrial fluxes through the Krebs cycle and ATP synthesis than in control. The similar reduction of both ATP synthesis and TCA cycle activity indicates a defect of mitochondrial number and/or function possibly resulting from age-associated mutations in control sites for mitochondrial DNA replication rather than a selective defect in mitochondrial energy coupling. Interestingly, these elderly nondiabetic humans also featured doubled intrahepatic triglyceride concentrations and more than 30% lower glucose-stimulated insulin secretion pointing to the role of mitochondrial dysfunction for explaining ectopic lipid deposition in other tissues than skeletal muscle and impaired insulin secretion in insulin resistance and T2DM. Finally, plasma FFA elevation for 48 h also resulted in decreased expression of connective tissue growth factor (CTGF) and a series of extracellular matrix genes such as matrix metalloproteinases (MMPs) and collagen. 24 Expression of CTF is stimulated by tumor growth factor-b, components of the renin-angiotensin system and hepatic growth factor. Since expression of these peptides was not altered in muscle from lipid infused humans, FFA or its metabolites could have regulated CTGF expression by releasing factors from adipocytes or macrophages or direct regulation within skeletal muscle. In combination with the above described activation of PKC and NFkB, FFA elevation can induce inflammatory processes that might further aggravate insulin resistance.
Conclusions
One might therefore hypothesize that increased fatty acid flux results in accumulation of FA-CoA within myocytes, which induces the following sequence of events ( Figure 1 ): (i) inhibition of proximal and distal steps of insulin signaling, (ii) reduction of insulin-(in)dependent glucose transport/ phosphorylation, (iii) decreased insulin-stimulated glycogen synthesis, (iv) impaired insulin-stimulated oxidative phosphorylation, (v) accumulation of ectopic triglycerides (IMCL), (vi) reduced expression of the PPARg coactivator-1 (PGC-1) and PGC-1-controlled genes involved in mitochondrial biogenesis and oxidative phosphorylation and possibly also (vii) initiation of inflammatory processes by activation of PKC and NFkB and decreased expression of MMPs. These alterations might lead to a vicious circle by further increasing the pool of intramyocellular FA-CoA and triglycerides (IMCL) (Figure 2 ). The described events bear some similarities with the adaptive changes to fasting and starving in that increased fatty acid flux to the skeletal muscle prevents excessive energy loss. The sequence of events may start with mitochondrial dysfunction in genetic insulin resistance and with increased intramyocellular lipids in environmental insulin resistance. Muscle triglycerides and mitochondrial function M Roden
